REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06369467 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-03-28 → 2027-08-31 3. primary completion date: 2028-03-28 → 2027-08-31 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical